首页> 中文期刊> 《中国法医学杂志》 >3种哌嗪类药物滥用研究进展

3种哌嗪类药物滥用研究进展

         

摘要

哌嗪类药物N-苄基哌嗪(BZP)、1-(3-氯苯基)哌嗪(mCPP)、1-(3-三氟甲基苯基)哌嗪(TFMPP)具有与MDMA相似的兴奋作用和致幻作用,成了迷幻药的替代品,在各国滥用的报道逐年增多。本文综述了3种哌嗪类药物在各国的管制、滥用情况、毒理作用、检测方法,希望为司法部门打击此类药物犯罪提供参考和借鉴。%Piperazine drugs, N - benzyl piperazine (BZP), 1 - (3 - chlorobenzene) piperazine (mCPP), 1 - (3 - three lfuorinated methyl phenyl) piperazine (TFMPP) have excitation and hallucinogenic effects similar to MDMA. They have became the alternative LSDs, abuse of substitues in the world reported increased year by year. The paper reviewed three piperazines regulation, abuse, toxicology, detection methods, and hope to provide a reference for judicial departments to crack down on the crime of the drug uses.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号